Related Experiment Video
Updated: Sep 28, 2025
07:41
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
9.1K
Genome-wide identification and analysis of prognostic features in human cancers
Joan C Smith1, Jason M Sheltzer2
1Yale University School of Medicine, New Haven, CT 06511, USA; Google, Inc., New York, NY 10011, USA.
Cell Reports
|March 30, 2022
Summary
This study identifies over 100,000 prognostic biomarkers from genomic data to predict cancer patient outcomes. Contrary to common belief, adverse biomarkers are not enriched for oncogenes or drug targets, highlighting new directions for cancer research.
Area of Science:
- Genomics
- Cancer Biology
- Biostatistics
Background:
- Accurate cancer patient risk assessment is crucial for clinical decisions.
- Identifying aggressive malignancies requires robust prognostic tools.
Purpose of the Study:
- To construct genome-wide survival models using multi-omic data.
- To identify significant prognostic biomarkers for cancer.
- To evaluate the association of adverse biomarkers with oncogenes and drug targets.
Main Methods:
- Integrated analysis of gene expression, copy number, methylation, and mutation data.
- Development of genome-wide survival models using data from 10,884 cancer patients.
- Statistical validation of prognostic biomarkers and their enrichment analysis.
Main Results:
- Identified over 100,000 significant prognostic biomarkers.
- Demonstrated genomic features predict patient outcomes in ambiguous cases.
- Found adverse biomarkers are not enriched for oncogenes or successful drug targets.
- Showed strongest adverse biomarkers are widely expressed cell-cycle and housekeeping genes.
Conclusions:
- The identified biomarkers provide a resource for prognostic analysis in cancer.
- Adverse biomarkers do not necessarily represent actionable cancer driver genes or therapeutic targets.
- Findings clarify the utility of patient survival data in preclinical cancer research and therapeutic development.
Related Concept Videos
01:11Genome-wide Association Studies-GWAS
14.5K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
14.5K
01:21Cancer Survival Analysis
472
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
472